Role of unusual CD4+ CD28- T cells in acute coronary syndrome

Molecular Biology Reports

Volumn 39, Issue 3, 2012, Pages 3337-3342

  Sun, Wenjie ^a   Zheng, Lihui ^a   Huang, Lijuan ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Acute coronary syndrome; CD4+ CD28 T cells

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD40 LIGAND; CD86 ANTIGEN; CHEMOKINE RECEPTOR CCR5; DEATH RECEPTOR 5; FAS ANTIGEN; GAMMA INTERFERON; HEAT SHOCK PROTEIN 60; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY; RANTES; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ACUTE CORONARY SYNDROME; ANTIGEN SPECIFICITY; ARTICLE; ATHEROSCLEROTIC PLAQUE; BIOLOGICAL ACTIVITY; BIOLOGICAL FUNCTIONS; CD4+ CD28- T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; HUMAN; IMMUNOREACTIVITY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; REGULATORY MECHANISM; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ACUTE CORONARY SYNDROME; ANTIGENS, CD28; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; EPITOPES; HUMANS; LYMPHOCYTE ACTIVATION; PLAQUE, ATHEROSCLEROTIC;

EID: 84863855759     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-1103-9     Document Type: Article

References (33)

1. Pryshchep S, Sato K, Goronzy JJ, Weyand CM (2006) T cell recognition and killing of vascular smooth muscle cells in acute coronary syndrome. Circ Res 98(9):1168-1176
2. Millonig G, Malcom GT, Wick G (2002) Molecular fingerprint of interferon-gamma inflammatory-immunological lesions in juvenile atherosclerosis from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study. Atherosclerosis 160(2): 441-448
3. Xu Q (2002) Role of heat shock proteins in atherosclerosis. Arterioscler Thromb Vasc Biol 22(10):1547-1559
4. Davenport P, Tipping PG (2003) The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice. Am J Pathol 163(3):1117-1125
5. Liuzzo G, Biasucci LM, Trotta G, Brugaletta S, Pinnelli M, Digianuario G, Rizzello V, Rebuzzi AG, Rumi C, Maseri A, Crea F (2007) Unusual CD4+ CD28null T lymphocytes and recurrence of acute coronary events. J Am Coll Cardiol 50(15): 1450-1458
6. Acuto O, Michel F (2003) CD28-mediated co-stimulation: a quantitative support for TCR signalling. Nat Rev Immunol 3(12):939-951
7. Alegre ML, Frauwirth KA, Thompson CB (2001) T-cell regulation by CD28 and CTLA-4. Nat Rev Immunol 1(3):220-228
8. Rizzello V, Liuzzo G, Brugaletta S, Rebuzzi A, Biasucci LM, Crea F (2006) Modulation of CD4+ CD28null T lymphocytes by tumor necrosis factor-alpha blockade in patients with unstable angina circulation. Circulation 113(19):2272-2277
9. Pasqui AL, Di Renzo M, Bova G, Maffei S, Pompella G, Auteri A, Puccetti L (2006) Pro-inflammatory/anti-inflammatory cytokine imbalance in acute coronary syndromes. Clin Exp Med 6(1):38-44
10. Weyand CM, Brandes JC, Schmidt D, Fulbright JW, Goronzy JJ (1998) Functional properties of CD4+ CD28-T cells in the aging immune system. Mech Ageing Dev 102(2-3):131-147
11. Nakajima T, Schulte S, Warrington KJ, Kopecky SL, Frye RL, Goronzy JJ, Weyand CM (2002) T-cell-mediated lysis of endothelial cells in acute coronary syndromes. Circulation 105(5):570-575
12. Morishita Y, Sao H, Hansen JA, Martin PJ (1989) A distinct subset of human CD4+ cells with a limited alloreactive T cell receptor repertoire. J Immunol 143(9):2783-2789
13. Vallejo AN, Weyand CM, Goronzy JJ (2004) T-cell senescence: a culprit of immune abnormalities in chronic inflammation persistent infection. Trends Mol Med 10(3):119-124
14. Zhang X, Niessner A, Nakajima T, Ma-Krupa W, Kopecky SL, Frye RL, Goronzy JJ, Weyand CM (2006) IL-12 induces T-cell recruitment into the atherosclerotic plaque. Circ Res 98(4): 524-531
15. Weber C, Schober A, Zemecke A (2004) Key regulators of mononuclear cell recruitment in atherosclerotic vascular disease. Arterioscler Thromb Vasc Biol 24(11):1997-2008
16. Trinchieri G (2003) Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3(2): 133-146
17. Michelsen KS, Doherty TM, Shah PK, Arditi M (2004) TLR signaling: an emerging bridge from innate immunity to atherogenesis. J Immunol 173(10):5901-5907
18. Vallejo AN (2005) CD28 extinction in human T cells: altered functions and the program of T-cell senescence. Immunol Rev 205:158-169
19. Anwar A, Zahid AA, Scheidegger KJ, Brink M, Delafontaine P (2002) Tumor necrosis factor-alpha regulates insulin-like growth factor-1 and insulin-like growth factor binding protein-3 expression in vascular smooth muscle. Circulation 105(10):1220-1225
20. van Leeuwen EM, Remmerswaal EB, Vossen MT, Rowshani AT, Wertheim-van Dillen PM, van Lier RA, ten Berge IJ (2004) Emergence of a CD4+ CD28-Granzyme B+, cytomegalovirusspecific T cell subset after recovery of primary cytomegalovirus infection. J Immunol 173(3):1834-1841
21. Zal B, Kaski JC, Arno G, Akiyu JP, Xu Q, Cole D, Whelan M, Russell N, Madrigal JA, Dodi IA, Baboonian C (2004) Heatshock protein 60-reactive CD4+ CD28null T cells in patients with acute coronary syndromes. Circulation 109(10):1230-1235
22. Park W, Weyand CM, Schmidt D, Goronzy JJ (1997) Co-stimulatory pathways controlling activation and peripheral tolerance of human CD4+ CD28-T cells. Eur J Immunol 27(5):1082-1087
23. Namekawa T, Snyder MR, Yen JH, Goehring BE, Leibson PJ, Weyand CM, Goronzy JJ (2000) Killer cell activating receptors function as costimulatory molecules on CD4+ CD28null T cells clonally expanded in rheumatoid arthritis. J Immunol 165(2): 1138-1145
24. Nakajima T, Goek O, Zhang X, Kopecky SL, Frye RL, Goronzy JJ, Weyand CM (2003) De novo expression of killer immunoglobulin-like receptors and signaling proteins regulates the cytotoxic function of CD4 T cells in acute coronary syndromes. Circ Res 93(2):106-113
25. Ucker DS, Meyers J, Obermiller PS (1992) Activation driven T cell death II. Quantitative differences alone distinguish stimuli triggering nontransformed T cell proliferation or death. J Immunol 149(5):1583-1592
26. Radvanyi LG, Mills GB, Miller RG (1993) Religation of the T cell receptor after primary activation of mature T cells inhibits proliferation and induces apoptic cell death. J Immunol 150(2): 5704-5709
27. Green JM, Noel PJ, Sperling AI, Walunas TL, Gray GS, Bluestone JA, Thompson CB (1994) Absence of B7-dependent responses in CD28-deficient mice. Immunity 1(6):501-508
28. Sperling AI, Green JM, Mosley RL, Smith PL, Dipaolo RJ, Klein JR, Bluestone JA, Thompson CB (1995) CD43 is a murine T cell costimulatory receptor that functions independently of CD28. J Exp Med 182(1):139-145
29. Schmidt D, Goronzy JJ, Weyand CM (1996) CD4+ CD7-CD28-T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J Clin Investig 97(9): 2027-2033
30. Zal B, Kaski JC, Akiyu JP, Cole D, Arno G, Poloniecki J, Madrigal A, Dodi A, Baboonian C (2008) Differential pathways govern CD4+ CD28-T cell proinflammatory and effector responses in patients with coronary artery disease. J Immunol 181(8):5233-5241
31. Sun W, Cui Y, Zhen L, Huang L (2011) Association between HLA-DRB1, HLA-DRQB1 alleles, and CD4(+)CD28(null) T cells in a Chinese population with coronary heart disease. Mol Biol Rep 38(3):1675-1679
32. Liuzzo G, Goronzy JJ, Yang H, Kopecky SL, Holmes DR, Frye RL, Weyand CM (2000) Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation 101(25):2883-2888
33. Sato K, Niessner A, Kopecky SL, Frye RL, Goronzy JJ, Weyand CM (2006) TRAIL-expressing T cells induce apoptosis of vascular smooth muscle cells in the atherosclerotic plaque. J Exp Med 203(1):239-250